يعرض 1 - 15 نتائج من 15 نتيجة بحث عن '"Shepherd, Stacie Peacock"', وقت الاستعلام: 0.38s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
    Academic Journal

    مصطلحات موضوعية: ddc:no

    Relation: Javle, Milind, Roychowdhury, Sameek, Kelley, Robin Kate, Sadeghi, Saeed, Macarulla, Teresa orcid:0000-0002-5856-4082 , Weiss, Karl Heinz, Waldschmidt, Dirk-Thomas, Goyal, Lipika, Borbath, Ivan, El-Khoueiry, Anthony, Borad, Mitesh J., Yong, Wei Peng, Philip, Philip A., Bitzer, Michael, Tanasanvimon, Surbpong, Li, Ai, Pande, Amit, Soifer, Harris S., Shepherd, Stacie Peacock, Moran, Susan, Zhu, Andrew X., Bekaii-Saab, Tanios S. and Abou-Alfa, Ghassan K. (2021). Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol. Hepatol., 6 (10). S. 803 - 816. SAN DIEGO: ELSEVIER INC. ISSN 2468-1253

  7. 7
    Academic Journal

    مصطلحات موضوعية: ddc:no

    Relation: Javle, Milind M., Roychowdhury, Sameek, Kelley, Robin Kate, Sadeghi, Saeed, Macarulla, Teresa, Waldschmidt, Dirk Thomas, Goyal, Lipika, Borbath, Ivan, El-Khoueiry, Anthony B., Yong, Wei-Peng, Philip, Philip Agop, Bitzer, Michael, Tanasanvimon, Suebpong, Pande, Amit, Shepherd, Stacie Peacock, Moran, Susan and Abou-Alfa, Ghassan K. (2021). Final results from a phase II study of infigratinib (BGJ398), an FGFR-selective tyrosine kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma harboring an FGFR2 gene fusion or rearrangement. J. Clin. Oncol., 39 (3). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

  8. 8
  9. 9
    Academic Journal
  10. 10
  11. 11
    Academic Journal

    المساهمون: The study was sponsored by AbbVie. AbbVie contributed to the study design, research, and interpretation of data, and the writing, reviewing, and approving of the publication.

    المصدر: Cancer Chemotherapy and Pharmacology ; volume 79, issue 3, page 587-594 ; ISSN 0344-5704 1432-0843

  12. 12
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal